NantCel is an offshoot of Soon-Shiong`s NantWorks conglomerate. Developing molecular-level cell-based treatments for diseases.
Minnetronix is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.
ChemoMetec is a worldwide leading manufacturer of automated cell counters and analysis equipment. We work closely with life science companies, research institutes, universities, hospitals, specialist clinics, and a wide range of food and beverage manuf...
Terumo Medical Corporation (TMC), a leading medical device manufacturer employs approximately 700 people in offices throughout the United States, with its corporate headquarters located in Somerset, NJ.